PL2848681T4 - Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki - Google Patents
Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matkiInfo
- Publication number
- PL2848681T4 PL2848681T4 PL14190638T PL14190638T PL2848681T4 PL 2848681 T4 PL2848681 T4 PL 2848681T4 PL 14190638 T PL14190638 T PL 14190638T PL 14190638 T PL14190638 T PL 14190638T PL 2848681 T4 PL2848681 T4 PL 2848681T4
- Authority
- PL
- Poland
- Prior art keywords
- faeces
- strains
- characterization
- isolation
- identification
- Prior art date
Links
- 238000012512 characterization method Methods 0.000 title 1
- 210000003608 fece Anatomy 0.000 title 1
- 210000004251 human milk Anatomy 0.000 title 1
- 235000020256 human milk Nutrition 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/ES2009/000130 WO2010103132A1 (es) | 2009-03-10 | 2009-03-10 | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
| EP14190638.8A EP2848681B1 (en) | 2009-03-10 | 2010-03-09 | Isolation, identification and characterization of strains with probiotic activity from the faeces of babies fed exclusively with breast milk |
| EP10750390.6A EP2407532B1 (en) | 2009-03-10 | 2010-03-09 | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2848681T4 true PL2848681T4 (pl) | 2017-10-31 |
| PL2848681T3 PL2848681T3 (pl) | 2017-10-31 |
Family
ID=42727821
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10750390T PL2407532T3 (pl) | 2009-03-10 | 2010-03-09 | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym pochodzących z kału niemowląt karmionych wyłącznie mlekiem matki |
| PL14190638T PL2848681T3 (pl) | 2009-03-10 | 2010-03-09 | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki |
| PL14190648T PL2848682T3 (pl) | 2009-03-10 | 2010-03-09 | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10750390T PL2407532T3 (pl) | 2009-03-10 | 2010-03-09 | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym pochodzących z kału niemowląt karmionych wyłącznie mlekiem matki |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14190648T PL2848682T3 (pl) | 2009-03-10 | 2010-03-09 | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8637297B2 (pl) |
| EP (3) | EP2848682B1 (pl) |
| CN (3) | CN102421889B (pl) |
| DK (3) | DK2848681T3 (pl) |
| ES (3) | ES2532095T3 (pl) |
| PL (3) | PL2407532T3 (pl) |
| RU (1) | RU2551315C2 (pl) |
| WO (2) | WO2010103132A1 (pl) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| AU2008231467A1 (en) * | 2007-03-28 | 2008-10-02 | Alimentary Health Limited | Probiotic Bifidobacterium strains |
| CA2807242C (en) | 2010-08-04 | 2017-05-02 | Thomas Julius Borody | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
| US9968638B2 (en) | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| RU2453591C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии |
| KR101228035B1 (ko) * | 2011-06-29 | 2013-01-30 | 주식회사 쎌바이오텍 | 신규한 유산균 및 이를 포함하는 당뇨병 예방 및 치료용 조성물 |
| US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| US10022407B2 (en) * | 2012-11-12 | 2018-07-17 | Compagnie Gervais Danone | Use of a lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance |
| ES2468040B1 (es) * | 2012-11-13 | 2014-12-26 | Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria (Inia) | Microorganismo aislado de leche materna y de heces de un lactante, y su uso como probiótico |
| CN102960599A (zh) * | 2012-11-19 | 2013-03-13 | 陕西科技大学 | 一种含益生元的双歧杆菌微胶囊的制备方法 |
| ITRM20130174A1 (it) * | 2013-03-22 | 2014-09-23 | Eurospital S P A | Ceppo di lactobacillus e suo uso come probiotico |
| JP6643988B2 (ja) * | 2013-08-09 | 2020-02-12 | エービー−バイオティクス，エセ．ア． | 乳児の過剰な泣きのためのプロバイオティクス |
| ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| WO2015042683A1 (en) * | 2013-09-26 | 2015-04-02 | Hassan Firoozmand | Biopolymer compositions comprising a plurality of treated single-celled microorganisms |
| KR102240196B1 (ko) * | 2014-03-24 | 2021-04-15 | 오츠카 세이야쿠 가부시키가이샤 | 신규한 락토바실러스 파라카세이 균주 |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| RU2605626C2 (ru) * | 2015-04-28 | 2016-12-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский технологический институт пищевой промышленности (университет)" | Способ получения бактериального препарата с пробиотической активностью |
| MX2017014488A (es) | 2015-05-14 | 2018-06-11 | Crestovo Holdings Llc | Composiciones para transplante de la flora fecal y metodos para elaborarlos y utilizarlos y dispositivos para suministrarlos. |
| JP6856968B2 (ja) | 2015-05-22 | 2021-04-14 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ | 自閉症スペクトラム障害および関連する症候を治療するための方法 |
| CN104894021B (zh) * | 2015-06-03 | 2018-02-09 | 宜兰食品工业股份有限公司 | 一种副干酪乳杆菌及其应用 |
| CN105176822B (zh) * | 2015-10-23 | 2019-01-11 | 广州康泽医疗科技有限公司 | 一种人类肠道益生菌的优化分离方法 |
| MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
| US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
| US11026978B2 (en) | 2016-10-11 | 2021-06-08 | Finch Therapeutics Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| EP3606541A1 (en) | 2017-04-05 | 2020-02-12 | Crestovo Holdings LLC | Compositions and methods for treating parkinson's disease (pd) and related disorders |
| WO2018218159A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
| CA3072032A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | Compositions and methods for maintaining and restoring a healthy gut barrier |
| CN112135520B (zh) * | 2018-01-03 | 2024-03-29 | 英凡特健康有限公司 | 测定肠道微生物组中生态失调的方法 |
| CN111868229B (zh) * | 2018-01-05 | 2024-06-18 | 益福生医股份有限公司 | 一种乳酸菌及其应用 |
| CN108315285A (zh) * | 2018-05-08 | 2018-07-24 | 西藏高原之宝牦牛乳业股份有限公司 | 一种副干酪乳杆菌及其制备方法 |
| CN111164201B (zh) * | 2018-07-02 | 2023-09-12 | 葡萄王生技股份有限公司 | 用于改善代谢症候群的副干酪乳杆菌gks6、其用途、医药组合物及可食用组合物 |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| CN109134628A (zh) * | 2018-09-26 | 2019-01-04 | 福建傲农生物科技集团股份有限公司 | 一种乳酸菌素plnE及其制备方法 |
| CA3114423A1 (en) | 2018-09-27 | 2020-04-02 | Finch Therapeutics Holdings Llc | Compositions and methods for treating epilepsy and related disorders |
| CN109536415B (zh) * | 2018-12-26 | 2021-12-07 | 江西仁仁健康产业有限公司 | 一种鼠李糖乳杆菌及其应用 |
| CN112912088A (zh) | 2019-01-16 | 2021-06-04 | N·V·努特里奇亚 | 用于轮状病毒引起的感染的具有非消化性寡糖的经发酵配方食品 |
| US11865151B2 (en) * | 2019-02-14 | 2024-01-09 | Gutsybio Inc. | Live biotherapeutics for the treatment of carbohydrate disorders |
| EP3718416B1 (en) | 2019-04-03 | 2024-05-29 | COREE S.r.l. | Production method to increase bioavailability of sugars from natural complex polysaccharides for human, animal and agricultural purposes |
| KR102139687B1 (ko) * | 2019-05-03 | 2020-07-30 | 주식회사 메디오젠 | 가드네렐라 바기날리스 및 칸디다 알비칸스에 항균 효과를 갖는 질염 치료 또는 개선용 유산균 mg4288 |
| JP7013419B2 (ja) * | 2019-08-07 | 2022-02-15 | 日清食品ホールディングス株式会社 | 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 |
| IT201900020422A1 (it) * | 2019-11-05 | 2021-05-05 | Sofar Spa | Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| EP3725167A1 (en) * | 2019-11-11 | 2020-10-21 | COREE S.r.l. | Synergistic blends of probiotics expressing improved beneficial activity for human host favourably interacting with food, particularly baby food |
| WO2021242057A1 (ko) * | 2020-05-28 | 2021-12-02 | 주식회사 바이오뱅크힐링 | 락토바실러스 속 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
| KR102296286B1 (ko) * | 2020-06-16 | 2021-09-01 | 주식회사 바이오뱅크힐링 | 락토바실러스 람노서스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
| CN113817622B (zh) * | 2020-06-18 | 2023-05-26 | 青岛蔚蓝生物股份有限公司 | 一株具有减轻致癌物对人体细胞基因毒性作用的长双歧杆菌及其应用 |
| CN111826312B (zh) * | 2020-07-10 | 2022-03-25 | 江南大学 | 一株可缓解苯并芘暴露的鼠李糖乳杆菌及其应用 |
| CN111733110B (zh) * | 2020-07-17 | 2021-10-22 | 佛山市朗芯生物科技有限公司 | 副干酪乳杆菌及其在制备治疗溃疡性结肠炎药物中的应用 |
| CN111944727B (zh) * | 2020-08-24 | 2021-12-03 | 汤臣倍健股份有限公司 | 一种短双歧杆菌207-1及其应用 |
| CN113265351B (zh) * | 2021-05-11 | 2022-05-06 | 昆明理工大学 | 一株乳杆菌w8172及其应用 |
| RU2766765C1 (ru) * | 2021-05-25 | 2022-03-15 | Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" | Способ лечения функциональных заболеваний желудочно-кишечного тракта у детей |
| CN113322216B (zh) * | 2021-07-30 | 2021-11-05 | 北京量化健康科技有限公司 | 一种副干酪乳杆菌b111h及其在代谢综合征中的应用 |
| KR102562507B1 (ko) * | 2021-12-08 | 2023-08-02 | 한국식품연구원 | 항염증 효과가 뛰어난 신규한 락토바실러스 파라카제이 아종 톨러란스 WiKim0148 및 이의 용도 |
| CN114113023B (zh) * | 2021-12-16 | 2024-04-26 | 郑州轻工业大学 | 基于单核增生李斯特菌来源的氮掺杂碳点的制备方法和应用 |
| CN114292779A (zh) * | 2021-12-22 | 2022-04-08 | 清远西周生物医药科技有限公司 | 一种副干酪乳杆菌冻干粉、其应用及制备方法 |
| CN114381411B (zh) * | 2022-03-23 | 2022-05-27 | 山东中科嘉亿生物工程有限公司 | 乳酸乳球菌jyll-60及其在制备提高免疫力的产品上的应用 |
| CN115998777B (zh) * | 2022-10-18 | 2023-11-17 | 汤臣倍健股份有限公司 | 副干酪乳杆菌207-27的用途 |
| CN116731891B (zh) * | 2022-12-07 | 2024-05-07 | 内蒙古科拓生物有限公司 | 一株短双歧杆菌b2798及其制备益生菌制剂的用途 |
| CN116396905A (zh) * | 2023-04-08 | 2023-07-07 | 威凯海思(山东)生物工程有限公司 | 一种短双歧杆菌hc2953、菌剂及其应用 |
| CN116855413B (zh) * | 2023-07-07 | 2024-02-09 | 镇江远森医药科技有限公司 | 利用鼠李糖乳杆菌YSs069制备调节人体微生态平衡的生物活性物质及其应用 |
| KR102700400B1 (ko) * | 2023-11-24 | 2024-09-02 | (주)마이크로바이옴 | 항균 활성 및 프로바이오틱스 특성을 갖는 글루텐 분해능이 있는 락토바실러스 파라카제이 glu70 균주 및 이의 용도 |
| CN117660253A (zh) * | 2023-12-10 | 2024-03-08 | 石河子大学 | 一种鼠李糖乳酪杆菌fmbl l23004 cnn、酸奶发酵剂、酸奶及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69219768T2 (de) * | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
| AU727940B2 (en) * | 1997-08-21 | 2001-01-04 | New Zealand Dairy Board | Immunity enhancing lactic acid bacteria |
| EP1034788A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
| ATE291353T1 (de) * | 1999-05-07 | 2005-04-15 | Gervais Danone Sa | Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen |
| FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| ES2314461T3 (es) * | 2003-10-24 | 2009-03-16 | N.V. Nutricia | Composicion simbiotica para bebes. |
| ITMI20042189A1 (it) * | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
| CN1259054C (zh) * | 2004-12-27 | 2006-06-14 | 孙文基 | 龙胆苦苷在制备抑制乙型肝炎病毒药物中的应用 |
| CA2604338A1 (en) * | 2005-04-13 | 2006-10-19 | Nestec S.A. | Infant formula with probiotics |
| EP2269465A1 (en) * | 2006-05-03 | 2011-01-05 | Probiotical S.p.a. | Compositions comprising Bifidobacterium adolescentis |
| US20100166721A1 (en) * | 2006-06-09 | 2010-07-01 | Fabiola Masri | Probotic compositions and uses thereof |
| US8066986B2 (en) * | 2007-02-01 | 2011-11-29 | Master Supplements, Inc. | Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms |
| EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
| EP1997499A1 (en) * | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
-
2009
- 2009-03-10 WO PCT/ES2009/000130 patent/WO2010103132A1/es active Application Filing
-
2010
- 2010-03-09 ES ES10750390.6T patent/ES2532095T3/es active Active
- 2010-03-09 PL PL10750390T patent/PL2407532T3/pl unknown
- 2010-03-09 EP EP14190648.7A patent/EP2848682B1/en active Active
- 2010-03-09 US US13/255,842 patent/US8637297B2/en active Active
- 2010-03-09 PL PL14190638T patent/PL2848681T3/pl unknown
- 2010-03-09 DK DK14190638.8T patent/DK2848681T3/en active
- 2010-03-09 EP EP14190638.8A patent/EP2848681B1/en not_active Not-in-force
- 2010-03-09 RU RU2011138363/10A patent/RU2551315C2/ru active
- 2010-03-09 CN CN201080020442.2A patent/CN102421889B/zh active Active
- 2010-03-09 EP EP10750390.6A patent/EP2407532B1/en active Active
- 2010-03-09 PL PL14190648T patent/PL2848682T3/pl unknown
- 2010-03-09 ES ES14190648.7T patent/ES2636944T3/es active Active
- 2010-03-09 CN CN201410478147.1A patent/CN104232545B/zh active Active
- 2010-03-09 CN CN201410476564.2A patent/CN104232544B/zh not_active Expired - Fee Related
- 2010-03-09 DK DK10750390.6T patent/DK2407532T3/en active
- 2010-03-09 DK DK14190648.7T patent/DK2848682T3/en active
- 2010-03-09 WO PCT/ES2010/000097 patent/WO2010103140A2/es active Application Filing
- 2010-03-09 ES ES14190638.8T patent/ES2632436T3/es active Active
-
2013
- 2013-03-15 US US13/841,604 patent/US20130280790A1/en not_active Abandoned
- 2013-03-15 US US13/841,135 patent/US20130280789A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010103132A1 (es) | 2010-09-16 |
| WO2010103140A2 (es) | 2010-09-16 |
| DK2848682T3 (en) | 2017-09-11 |
| EP2848681A1 (en) | 2015-03-18 |
| EP2407532B1 (en) | 2014-12-10 |
| US20130280789A1 (en) | 2013-10-24 |
| CN104232545A (zh) | 2014-12-24 |
| EP2848681B1 (en) | 2017-04-12 |
| US20120076829A1 (en) | 2012-03-29 |
| RU2551315C2 (ru) | 2015-05-20 |
| PL2848681T3 (pl) | 2017-10-31 |
| RU2011138363A (ru) | 2013-04-20 |
| CN102421889A (zh) | 2012-04-18 |
| EP2407532A4 (en) | 2013-04-10 |
| CN104232544A (zh) | 2014-12-24 |
| ES2636944T3 (es) | 2017-10-10 |
| ES2632436T3 (es) | 2017-09-13 |
| US20130280790A1 (en) | 2013-10-24 |
| US8637297B2 (en) | 2014-01-28 |
| PL2407532T3 (pl) | 2015-06-30 |
| CN102421889B (zh) | 2014-10-29 |
| DK2848681T3 (en) | 2017-07-24 |
| WO2010103140A3 (es) | 2010-11-04 |
| ES2532095T3 (es) | 2015-03-24 |
| EP2848682A1 (en) | 2015-03-18 |
| CN104232545B (zh) | 2017-11-21 |
| DK2407532T3 (en) | 2015-03-09 |
| EP2407532A2 (en) | 2012-01-18 |
| EP2848682B1 (en) | 2017-05-31 |
| PL2848682T3 (pl) | 2017-12-29 |
| CN104232544B (zh) | 2017-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2848681T3 (pl) | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki | |
| PL2429557T3 (pl) | Preparaty do odżywiania niemowląt zawierające probiotyczne mikroorganizmy | |
| HK1217411A1 (zh) | 乳製品及方法 | |
| ZA201108615B (en) | Shelf-stable fermented dairy products and methods of making same | |
| PL2323493T3 (pl) | Produkty probiotyczne dla niemowląt | |
| AP2011005838A0 (en) | Process for the preparation of fischer-tropsch catalysts and their use. | |
| PL2498789T3 (pl) | Probiotyczny szczep bifidobacterium | |
| PT2340754E (pt) | Dispositivo para a produção de espuma de leite ou afins | |
| PL2442661T3 (pl) | Sposób wytwarzania wysoce dyspergowalnej mąki pełnoziarnistej | |
| ZA201203668B (en) | Pet food compositions including probiotics and methods of manufacturing and use thereof | |
| ZA201109072B (en) | Probiotic juice drink | |
| LT2632277T (lt) | Pieno produktas ir gamybos būdas | |
| GB2481169B (en) | A reduced lactose milk product and a process for the preparation thereof | |
| PL2789279T3 (pl) | Układ do wytwarzania napojów, w szczególności napojów na bazie mleka takich jak cappuccino, czekolada i tym podobnych | |
| HK1162879A1 (en) | Baby food based on fat of dairy origin | |
| PL2707478T3 (pl) | Probiotyczne szczepy bakterii i zawierająca je kompozycja symbiotyczna przeznaczona do żywności dla niemowląt | |
| IL226459A0 (en) | A hydrolyzed drink for babies | |
| GB0904557D0 (en) | Whey or raw milk demineralisation and fractionation | |
| HK1167578A1 (en) | Carbonated drink comprising soybean flour or soybean milk | |
| HK1122959A1 (en) | Milk product and preparation thereof | |
| HK1150509A1 (en) | Heating cup assembly and soybean milk machine | |
| EP2451270A4 (en) | ELEMENTS OF A MILKING SYSTEM AND METHODS OF FORMATION AND MONITORING | |
| GB201201046D0 (en) | Container for dairy products and the like | |
| PL388521A1 (pl) | Sposób wytwarzania jogurtu z mleka niskolaktozowego | |
| PL389279A3 (pl) | Sposób wytwarzania jogurtu z mleka niskolaktozowego |